Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives in spicing up proteomics with splicing.

Jasminka Godovac-Zimmermann1, Oliver Kleiner, Larry R Brown

  • 1Center for Molecular Medicine, Department of Medicine, University College London, London, UK. j.godovac-zimmermann@ucl.ac.uk

Proteomics
|February 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction.

Nature communications·2024
Same author

The administration of amnion-derived multipotent cell secretome ST266 protects against necrotizing enterocolitis in mice and piglets.

American journal of physiology. Gastrointestinal and liver physiology·2022
Same author

Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.

Translational vision science & technology·2022
Same author

Quantification of FAM20A in human milk and identification of calcium metabolism proteins.

Physiological reports·2021
Same author

Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.

PloS one·2021
Same author

Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2020

Proteomics in higher eukaryotes faces sensitivity and quantitation limits. New top-down proteomics technologies are emerging to enable physiologically relevant studies in medicine and biology.

Area of Science:

  • Proteomics
  • Molecular Biology
  • Genomics

Background:

  • The post-genomics era has accelerated biological understanding, raising new challenges for proteomics.
  • Higher eukaryotes generate protein diversity through alternative promoters, splicing, RNA editing, and post-translational modifications.

Purpose of the Study:

  • To address the limitations in current proteomics applicable to higher eukaryotes.
  • To highlight the necessity of advanced quantitative proteomics for studying complex biological systems.

Main Methods:

  • Discusses limitations in sensitivity, absolute quantitation, and protein structure characterization.
  • Highlights the need for quantitative, top-down proteomics analyses of complete proteins.

Main Results:

Related Experiment Videos

  • Current proteomics methods are fundamentally limited for higher eukaryotes.
  • Sub-attomole level analyses of complete proteins are required for physiologically relevant studies.

Conclusions:

  • Emerging proteomics technologies are crucial for advancing cellular biology and medicine.
  • Future proteomics research requires enhanced sensitivity and quantitation for higher eukaryotes.